Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Adv Exp Med Biol. 2010;660:173-81. doi: 10.1007/978-1-60761-350-3_16.
High density lipoproteins (HDL) not only provide a serum transport vector for paraoxonase-1 (PON1) but also contribute to enzyme activity, stability and, consequently, function. The contribution of the apolipoprotein (apo) components of HDL to overall PON1 activity and function is not clearly established. ApoAI appears of major importance in defining serum PON1 activity and stability, but in the context of an interaction with the phospholipid fraction of HDL. This may involve a role in establishing the architecture of the HDL particle that optimally integrates the PON1 peptide. As the second, major structural peptide of HDL, apoAII may accomplish a similar role. These apolipoproteins, together with others associated with HDL, may also exert a more indirect influence on PON1 function by sequestering oxidised lipids that could compromise enzyme activity. The latter has been exploited therapeutically to give rise to apolipoprotein mimetic peptides that may be useful in limiting oxidative stress within the lipoprotein system, thus permitting PON1 activity to be maximally expressed.
高密度脂蛋白(HDL)不仅为对氧磷酶 1(PON1)提供血清转运载体,而且有助于酶的活性、稳定性,进而影响其功能。然而,HDL 的载脂蛋白(apo)成分对 PON1 整体活性和功能的贡献尚不清楚。apoAI 对确定血清 PON1 活性和稳定性具有重要意义,但这与 HDL 磷脂部分的相互作用有关。这可能涉及到建立 HDL 颗粒结构的作用,使 PON1 肽能够最佳整合。apoAII 作为 HDL 的第二种主要结构肽,可能发挥类似的作用。这些载脂蛋白与与 HDL 相关的其他载脂蛋白一起,也可能通过隔离可能损害酶活性的氧化脂质,对 PON1 功能产生更间接的影响。后者已被用于治疗,产生载脂蛋白模拟肽,这可能有助于限制脂蛋白系统中的氧化应激,从而使 PON1 活性得到最大表达。